Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Maj 2021

Planlagt Fastgjort Låst Flyttet Genmab
1.2k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • E Offline
    E Offline
    E_L
    wrote on sidst redigeret af
    #815

    and one more maintenance on the Auriga trial, Dara vs SOC https://meetinglibrary.asco.org/record/201317/abstract

    1 Reply Last reply
    0
    • BulderB Offline
      BulderB Offline
      Bulder
      wrote on sidst redigeret af
      #816

      I wonder if they'll wait for that study before they file dara as maintenance, or if Cass part 2 is enough.

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #817

        Winkel didn't answer that Q, but on the other hand he said "We fully expect a number of new label extensions to be executed in the coming time."

        1 Reply Last reply
        0
        • BulderB Offline
          BulderB Offline
          Bulder
          wrote on sidst redigeret af
          #818

          I assume "a number of" is more than 1.

          1 Reply Last reply
          0
          • E Offline
            E Offline
            E_L
            wrote on sidst redigeret af
            #819

            we'll also see more extensions being requested by other companies , like Amgen for Carfilzomib, just as JNJ included Revlimid in many of the extensions

            1 Reply Last reply
            0
            • E Offline
              E Offline
              E_L
              wrote on sidst redigeret af
              #820

              or like AbbVie for Lemzoparlimab , whatever that is, never heard of it, New trial - https://clinicaltrials.gov/ct2/show/NCT04895410

              1 Reply Last reply
              0
              • E Offline
                E Offline
                E_L
                wrote on sidst redigeret af
                #821

                Daratumumab and Pomalidomide in Previously Treated Patients With AL Amyloidosis (DarPAL) - New trial https://clinicaltrials.gov/ct2/show/NCT04895917

                1 Reply Last reply
                0
                • D Offline
                  D Offline
                  deleted-user
                  wrote on sidst redigeret af
                  #822

                  Det er en meget lille, men insisterende (!) kø, ved indgangen til Genmab i dag.

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #823

                    Og de behøver ikke vise coronapas for at komme ind.

                    1 Reply Last reply
                    0
                    • BulderB Offline
                      BulderB Offline
                      Bulder
                      wrote on sidst redigeret af
                      #824

                      US har helt skiftet farve. NBI mørkegrøn.

                      1 Reply Last reply
                      0
                      • DarvinD Offline
                        DarvinD Offline
                        Darvin
                        wrote on sidst redigeret af
                        #825

                        Og - de er ikke mindre glade for Genmab i dag derovre 🙂

                        1 Reply Last reply
                        0
                        • A Offline
                          A Offline
                          AaBforever
                          wrote on sidst redigeret af
                          #826

                          Pt omregnet 2375

                          1 Reply Last reply
                          0
                          • BulderB Offline
                            BulderB Offline
                            Bulder
                            wrote on sidst redigeret af
                            #827

                            Den afsluttende stigning satte ind præcis kl 15.30. Altså igen sammenfaldende med åbning i us.

                            1 Reply Last reply
                            0
                            • B Offline
                              B Offline
                              bibob
                              wrote on sidst redigeret af
                              #828

                              Numab to Challenge Genmab. https://www.fiercebiotech.com/biotech/numab-raises-111m-to-challenge-genmab-biontech-for-emerging-pd-l1-opportunity?mkt_tok=Mjk0LU1RRi0wNTYAAAF9KZ6oid8AkIeGz8s6ArzMSHvPrilYLivK4Uu2cmcMTZaUO4VXqe-6KB103r4l1ChL1Ujf4E0b_8rUyMBdW_bfIY9WC0wj55fZVTen9vaOvInqucT9yg&mrkid=41140432

                              1 Reply Last reply
                              0
                              • Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktørH Offline
                                Helge_LarsenPI-redaktør
                                wrote on sidst redigeret af
                                #829

                                God morgen. 🙂

                                1 Reply Last reply
                                0
                                • Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktørH Offline
                                  Helge_LarsenPI-redaktør
                                  wrote on sidst redigeret af
                                  #830

                                  Asien: Tokyo trækker op i blandede markeder - NY https://www.proinvestor.com/investornyt/675281/asien-tokyo-traekker-op-i-blandede-markeder-ny

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #831

                                    Genmab: Udviklingschef sælger aktier for 283.118 dollar https://www.proinvestor.com/investornyt/675284/genmab-udviklingschef-saelger-aktier-for-283118-dollar

                                    1 Reply Last reply
                                    0
                                    • Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktørH Offline
                                      Helge_LarsenPI-redaktør
                                      wrote on sidst redigeret af
                                      #832

                                      Fredagens aviser med Rockwool, Maersk Drilling og Jeudan
                                      https://www.proinvestor.com/investornyt/675278/fredagens-aviser-med-rockwool-maersk-drilling-og-jeudan

                                      1 Reply Last reply
                                      0
                                      • P Offline
                                        P Offline
                                        Plimsoller
                                        wrote on sidst redigeret af
                                        #833

                                        God morgen 🙂

                                        1 Reply Last reply
                                        0
                                        • D Offline
                                          D Offline
                                          deleted-user
                                          wrote on sidst redigeret af
                                          #834

                                          Godmorgen. Genmab og ledelsen har formentligt glemt, at der en notering i danske kroner....

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger